A 37-year-old man presented with a one year history of diminished libido and a six month history of poor concentration and headaches. No visual field changes were identified. Laboratory testing revealed normal blood hormone levels of total testosterone (10.16 nmol/L, normal 6.7-28.9), growth hormone (0.0 ng/ml, normal<5.0), insulin-like growth factor (132 ng/ml, normal 48-255), thyroid stimulating hormone (2.48 mUI/ml, normal 0.5-6.0), free thyroxin (0.98 ng/dl, normal 0.8-1.8), and cortisol (8.7 mcg/ml, normal 5-25). Blood prolactin levels were mildly elevated (131 ng/ml, normal 0-15), with decreased blood levels of luteinizing hormone (0.09 mUI/ml, normal 2-12), and follicle stimulating hormone (0.0 mUI/ml, normal 1-8).
surgery a soft, highly vascular lesion was identified in the region of the neurohypophysis which was partially resected. Gross total resection was not attempted in order to avoid iatrogenic neuroendocrine deficits. The post-operative evolution was uneventful.
The resected specimen was fixed in formalin and embedded in paraffin. Hematoxylin and eosin (H&E) stained sections demonstrated a proliferation of monotonous spindled cells with round to ovoid nuclei and modest eosinophilic cytoplasm ( Figure  2 ). Mitotic figures were not identified. The tumor contained scattered admixed lymphocytes and macrophages. No Herring bodies, Rosenthal fibers, eosinophilic granular bodies, or oncocytic appearing cells were apparent. The tumor cells were PAS negative.
For immunohistochemistry four micrometer sections from the formalin-fixed paraffin embedded tissue were stained with the streptavidin-biotin-peroxidase method. The tumor cells were strongly positive for S-100 protein (highlighting both tumor cell nuclei and cytoplasm). Glial fibrillary acidic protein (GFAP) showed patchy positivity throughout the tumor. Vimentin and vascular endothelial growth factor (VEGF) were diffusely Pituicytomas are postulated to arise in pituicytes, a specialized glial cell of the posterior pituitary. A recent series studied two cases of pituicytoma with array comparative genomic hybridization and described unique genetic alterations, but interestingly also noted several alterations previously characterized in pituitary adenomas including chromosomal imbalances on 1p, 5p, 14q, and 22q 3 . It has also recently been proposed that immunohistochemical staining for EMA may prove useful in distinguishing this tumor from spindle cell oncocytoma of the adenohypophysis, another spindled vascular tumor of the sellar region 4 . Our case showed strong and diffuse immunohistochemical labeling for VEGF. Vascular endothelial growth factor is a vascular mitogen that increases capillary permeability and plays an important role in glioma neovascularity and peritumoral edema 5 . The VEGF expression has been reported in several tumors of the sella, including pituitary adenomas, and craniopharyngioma. Expression of this marker does not imply aggressive behavior, or increased propensity for invasion. As seen in our case, pituicytomas are highly vascular, and may bleed profusely as a consequence of surgical manipulation. The
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Figure 2: A) H&E stained section (400x), B) S100 immunostaining (400x) showing diffuse cytoplasmic and nuclear labeling, C) Ki67 immunostaining (400x) labels approximately 1% of cells, D) VEGF immunostaining (400x) shows diffuse cytoplasmic positivity, E) Topoisomerase II alpha immunostaining (630x) labels rare tumor cell nuclei, F) Electron microscopy (6000x) showing an absence intercellular adhesions.
extensive vascularity can hinder the surgeon's ability to achieve a gross total resection and, in the majority of reported cases, only a subtotal resection was possible. This has led some authors to suggest pre-operative embolization in cases where the pathology is known prior to resection. Our results warrant further investigation into VEGF expression in these tumors, and anti-VEGF therapy may prove useful in the management of patients with pituicytoma.
Pitucytomas are considered benign, indolent, hormonally inactive neoplasms. They most commonly present with endocrine and visual abnormalities secondary to the mass effect. The slow growth rate of this tumor may account for the lack of diabetes insipidus, despite the typical location in the posterior pituitary. In our case, the tumor was associated with a mild increase in blood prolactin levels as a consequence of "stalkeffect".
In pituicytomas the Ki67 nuclear labeling index is typically low (<2%) and mitotic activity is inconspicuous, though rare cases of pituicytoma with increased mitotic activity (5/10 high powered fields) and Ki67 labeling (5%) have been reported. Immunohistochemical analysis of markers of cellular proliferation in our case are consistent with the low proliferative activity traditionally described in these tumors. Ki67 labeled fewer than 1% of tumor cell nuclei overall. P27 is a cyclindependant kinase inhibitor. Decreased levels and abnormal nonnuclear localization have been reported to be associated with aggressive behavior. Our case showed no evidence of abnormal cytoplasmic relocalisaiton. Topoisomerase IIalpha (Topo IIalpha) is a marker of cell proliferation. Increased expression of this marker as a percentage of tumor cell nuclei has also been correlated with aggressive behavior (infiltration and metastatic potential) in cases of pituitary adenoma. In our case of pituicytoma no increase in Topo IIalpha nuclear labeling was seen. These additional markers of proliferative activity confirm the currently held view that pituicytomas are slow-growing neoplasms, and that the prognosis is excellent for patients with this rare glial neoplasm of the neurohypophysis.
